Ann: Two PTX abstracts accepted at prestigious ISCT conference, page-11

Does anyone find it interesting that, firstly, Bec's poster presentation on CellPryme is specific to breast cancer?.... and that OmniCAR is being presented by Dr Kevin Sek of Peter Mac? What new pre-clinical data will be released to the market at the end of the month / early June?

The details of the presentations are as follows:

CellPryme ISCT Poster Presentation Session: Poster Reception 2 Abstract number: 1050 Title: “Improving CAR T cell efficacy in a pre-clinical model of breast cancer through modified manufacturing methods and adjuvant therapy.” Presenter: Dr. Rebecca Lim, SVP – Scientific Affairs, Prescient Therapeutics Date & Time: 1st June 2023, 6:00 to 7:30 pm

OmniCAR ISCT Poster Presentation Session: Poster Reception 2 Abstract number: 1076 Title: “OmniCAR – A universal CAR-T cell therapy using covalent Spytag/Spycatcher binding to target multiple antigens in different tumors.”Presenter: Dr. Kevin Sek, Post-doctoral scientist, Peter MacCallum Cancer Centre Date & Time: 1st June 2023, 6:00 to 7:30 pm